|
|
Publication |
|
Volumetric absorptive microsampling (VAMS) for the quantification of ten kinase inhibitors and determination of their in vitro VAMS-to-plasma ratio. Zimmermann S, Aghai F, Schilling B, Kraus S, Grigoleit GU, Kalogirou C, Goebeler ME, Jung P, Pelzer T, Klinker H, Isberner N, Scherf-Clavel O. J Pharm Biomed Anal. 2022 Mar 20;211:114623. doi: 10.1016/j.jpba.2022.114623. Epub 2022 Jan 29.
|
|
Letermovir exposure in transplant patients with end-stage renal disease on renal replacement therapy. Isberner N, Van Daele R, Klinker H, Kraus S, Aghai F, De Vlieger G, Kuypers D, Debaveye Y, Spriet I. J Antimicrob Chemother. 2021 Sep 2:dkab316. doi: 10.1093/jac/dkab316. Online ahead of print.
|
|
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice-a prospective single-center trial. Isberner N, Kraus S, Grigoleit GU, Aghai F, Kurlbaum M, Zimmermann S, Klinker H, Scherf-Clavel O. Cancer Chemother Pharmacol. 2021 Sep 10. doi: 10.1007/s00280-021-04351-w. Online ahead of print.
|
|
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma. Aghai F, Zimmermann S, Kurlbaum M, Jung P, Pelzer T, Klinker H, Isberner N, Scherf-Clavel O. Anal Bioanal Chem. 2020 Nov 6:1-14. doi: 10.1007/s00216-020-03031-7. Online ahead of print.
|
|
Quantification of letermovir in human serum using high-performance liquid chromatography with diode array detection. Isberner N, Aghai F, Schirmer D, Kraus S, Grigoleit GU, Klinker H. J Chromatogr B Analyt Technol Biomed Life Sci. 2020 Nov 30;1159:122399. doi: 10.1016/j.jchromb.2020.122399. Epub 2020 Oct 12.
|
|
Determination of Letermovir Serum Levels Can Be Useful in High-Risk Clinical Settings. Isberner N, Aghai F, Schirmer D, Bolz M, Kraus S, Grigoleit GU, Klinker H. J Pediatric Infect Dis Soc. 2020 Jul 13;9(3):402-403. doi: 10.1093/jpids/piaa036.
|
|
|